Comprehensive screening, early detection, diagnosis, and preventive care for cervical abnormalities using Pap smear, HPV testing, and colposcopy.
Cervical cancer screening is a critical preventive health measure that detects pre-cancerous and cancerous changes in the cervix before symptoms develop. When detected early, cervical cancer is highly treatable with excellent survival rates exceeding 95%. Screening typically involves Pap smear testing, HPV (Human Papillomavirus) testing, or both, depending on age and risk factors.
Colposcopy is a specialized diagnostic procedure performed when screening results are abnormal. It provides magnified visualization of the cervix to identify areas of concern and obtain tissue samples for biopsy if needed. Combined with HPV testing and appropriate follow-up, these screening and diagnostic tools offer comprehensive cervical cancer prevention and early detection.
Human Papillomavirus infection is the primary risk factor for cervical cancer, transmitted through sexual contact. Most HPV infections clear naturally, but persistent high-risk strains can lead to precancerous changes requiring monitoring and management.
Pap smear results showing dysplasia (abnormal cell growth) ranging from mild to severe indicate need for further evaluation with colposcopy and HPV testing to determine appropriate follow-up and treatment strategies.
Visual abnormalities detected during colposcopy including acetowhite lesions, punctuation, or mosaic patterns indicate areas requiring tissue biopsy for definitive diagnosis of cervical pathology.
Persistent high-risk HPV infection over time significantly increases cervical cancer risk. HPV testing helps identify women needing closer surveillance and colposcopy regardless of Pap smear results.
Quick 1-2 minute test where cells are gently scraped from the cervix using a brush or spatula and examined under microscope for dysplasia or malignancy. Results guide need for HPV testing or colposcopy. Recommended every 3 years for ages 21-65.
Laboratory test to detect human papillomavirus DNA in cervical cells, identifying high-risk strains associated with cervical cancer. HPV testing provides additional risk stratification beyond Pap smear results and guides follow-up recommendations.
15-20 minute office procedure using colposcope (magnifying microscope) to visualize cervix after applying acetic acid. Abnormal areas are identified and biopsied if needed. Allows precise diagnosis and treatment of cervical lesions.
For mild abnormalities or HPV without dysplasia, close follow-up with repeat Pap smear, HPV testing, and colposcopy at specified intervals ensures early detection of progression while avoiding overtreatment of self-resolving infections.
Minimally invasive techniques including cryotherapy (freezing), loop electrosurgical excision procedure (LEEP), or laser ablation effectively treat precancerous cervical lesions with high cure rates, minimal side effects, and preservation of cervical function.
Tissue samples obtained during colposcopy are examined to confirm diagnosis, classify grade of dysplasia (CIN 1, 2, or 3), and guide treatment decisions. Ensures appropriate management and prevents undertreatment of serious lesions.
Extensive experience in colposcopy, cervical pathology, and cancer screening with expertise in managing complex cases and applying latest evidence-based recommendations for optimal outcomes.
Emphasis on comprehensive cervical cancer prevention through proper screening protocols, HPV vaccination counseling, and patient education to reduce cancer incidence and improve population health.
Sensitive, patient-centered approach recognizing anxiety around screening results. Thorough counseling, clear communication of findings, and supportive guidance throughout evaluation and treatment process.
A colposcopy is a medical examination procedure in which a specialized microscope (colposcope) is used to magnify the cervix and vagina, typically 6-40 times magnification. It allows detailed visualization of cervical tissue to evaluate abnormal Pap test results or HPV infection. If concerning areas are identified, tissue biopsies may be taken during the procedure for laboratory analysis. The procedure takes 15-20 minutes and is performed in an office setting.
Most women find colposcopy mildly uncomfortable but not painful. The colposcope does not enter the cervix—it remains outside and magnifies the view. Acetic acid solution may cause mild stinging. Biopsies can cause cramping or brief sharp sensations. Discomfort is usually minimal and brief. Over-the-counter pain medication 30 minutes before can help if you're anxious. Communication with Dr. Sabnis about your concerns ensures a comfortable experience.
Cervical cancer is highly preventable when detected early through screening. The vast majority of cases (95%+) can be cured if caught in early stages before symptoms develop. Screening identifies HPV infection and precancerous changes (dysplasia) that can be treated before they progress to cancer. Regular screening has reduced cervical cancer deaths by over 75% in developed countries with organized screening programs. It's one of the most effective cancer prevention strategies available.
Screening recommendations vary by age and risk factors. Standard guidelines recommend: Pap smear every 3 years starting at age 21 for sexually active women; every 5 years for women 30-65 with HPV testing if negative; screening may be skipped in women with prior hysterectomy and cervix removal; HPV vaccination is recommended for ages 9-45. Women with abnormal results, immunosuppression, or other risk factors may need more frequent screening. Dr. Sabnis will recommend an appropriate screening schedule based on your individual risk profile.
Abnormal Pap results don't mean cancer. Results are classified by severity (ASCUS, LSIL, HSIL, etc.), and management depends on the classification, HPV status, and your age. Options include HPV reflex testing, repeat Pap smear in 6-12 months, or colposcopy for further evaluation. HPV-positive mild changes may resolve spontaneously with surveillance, while higher-grade changes typically warrant colposcopy and possible treatment. Dr. Sabnis will explain your specific results and recommend appropriate follow-up based on established guidelines.
Yes, cervical cancer is largely preventable through HPV vaccination and regular screening. HPV vaccines (Gardasil, Cervarix) prevent infection with high-risk HPV strains that cause most cervical cancers. When combined with regular Pap smear and HPV screening, vaccine coverage exceeds 95% cancer prevention. Additional prevention strategies include practicing safe sex, not smoking, maintaining healthy immune function, and avoiding unnecessary antibiotics. For unvaccinated women, regular screening with appropriate follow-up significantly reduces cancer risk through early treatment of precancerous changes.
Don't delay your cervical cancer screening. Early detection through regular Pap smears, HPV testing, and timely evaluation can help prevent cervical cancer and protect your long-term health. Book your appointment with Dr. Aneesh Sabnis today.